SCHEMBL17065013

SCHEMBL17065013

CC(=O)C(c1cccnc1)C1CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.44
CYP3A5 P20815 1/20 0.44
POLB P06746 1/20 0.43
TSHR P16473 2/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP17A1 P05093 3/20 0.43
CYP19A1 P11511 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TBXAS1 P24557 2/20 0.42
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 3/20 0.41
FAAH O00519 1/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689108 0.90 ALDH1A1 (0.46) CYP3A4CYP3A5POLBMAPTHSD17B10
SCHEMBL28143235 0.82 TP53 (0.53) POLBTSHRMAPTSMN1; SMN2LMNA
SCHEMBL28144222 0.79 RAB9A (0.58) CYP3A4POLBHSD17B10LMNAL3MBTL1
SCHEMBL15797709 0.78 SLC6A4 (0.49) SLC6A2SLC6A4CYP2D6SLC6A3
SCHEMBL4239134 0.78 SLC6A3 (0.54) CYP3A4TSHRSLC6A2SLC6A4LMNA
SCHEMBL15797564 0.78 CYP3A4 (0.51) CYP3A4CYP3A5FAAH
SCHEMBL24016014 0.77 POLB (0.53) CYP3A4POLBTSHRMAPTHSD17B10
SCHEMBL15797674 0.77 CHRM1 (0.44) MAPTLMNAALDH1A1
Hydrochloric Acid SCHEMBL15797820 0.77 SLC6A4 (0.48) SLC6A2SLC6A4CYP2D6SLC6A3
SCHEMBL14284025 0.75 SMN1; SMN2 (0.50) POLBSMN1; SMN2TBXAS1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3355890-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2018-08-08 EP disclosed
EP-3113772-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2017-01-11 EP disclosed
WO-2015134998-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2015-09-11 WO disclosed